Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.
第一作者:
G,Chung-Faye
第一单位:
CRC Institute of Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TA, United Kingdom.
作者:
医学主题词
腹痛(Abdominal Pain);腺病毒科(Adenoviridae);成年人(Adult);老年人(Aged);厌食(Anorexia);抗肿瘤药(Antineoplastic Agents);氮丙啶类(Aziridines);腹泻(Diarrhea);剂量效应关系, 药物(Dose-Response Relationship, Drug);疲劳(Fatigue);女(雌)性(Female);胃肠肿瘤(Gastrointestinal Neoplasms);遗传载体(Genetic Vectors);人类(Humans);注射, 腹腔内(Injections, Intraperitoneal);注射, 静脉内(Injections, Intravenous);男(雄)性(Male);中年人(Middle Aged);恶心(Nausea);硝基还原酶类(Nitroreductases);药物前体(Prodrugs);治疗结果(Treatment Outcome);呕吐(Vomiting)
PMID
11555577
发布时间
2021-11-09
- 浏览25
Clinical cancer research
2662-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



